Recent updates in hematology & oncology

Trials show, azacitidine & pembrolizumab combination is safe, feasible and well-tolerated for relapsed and refractory AML. Explore more trends in hematology & oncology at: https://hematology.cmesociety.com 

Recent Trends in Hematology/ Oncology

Research shows that combination of humanized anti-CD19 and anti-B-cell maturation antigen chimeric antigen receptor T-cells shows activity for relapsed or refractory multiple myeloma. Explore more hemonc at: http://bit.ly/2xaW3zT  

World Hematology 2020

Pulsus Group is glad to announce the 2020 conference in the Hematology and Oncology series, the 12^th World Hematology and Oncology Congress, scheduled to be held on March 2- 3, 2020 at Edinburgh, Scotland around the theme “Unravelling the enigmas in hematology & oncology”. We cordially invite all to join us at the event to explore every single aspect of hematology & oncology. Get to know more details at: World Hematology 2020

Dogs detect human Cancers

Research suggests that dogs can detect many types of cancers in humans.

Like many other diseases, cancers leave specific traces, or odor signatures, in a person’s body and bodily secretions. Cancer cells, or healthy cells affected by cancer, produce and release these odor signatures.

Depending on the cancer type, dogs are able to detect these signatures in a person’s:

• skin
• breath
• urine
• feces
• sweat

Dogs can detect these odor signatures and, with training, alert people to their presence. People refer to dogs that undergo training to detect certain diseases as medical detection dogs.

They detect some substances in very low concentrations, as low as parts per trillion, which makes their noses sensitive enough to detect cancer markers in a person’s breath, urine, and blood.

The fact that dogs can detect cancer has significant benefits for humans. Using dogs to detect and diagnose cancer is a low-risk, noninvasive method.

Medical detection dogs present few side effects and may offer advantages because they are mobile, can begin work quickly, and can trace an odor to its source.

They also have the potential for use in patient care settings or laboratories to identify cancer in tissue samples from people with suspected cancers.

Dogs’ abilities may also help with developing machines that can reliably detect odor signatures from cancer, such as electronic noses.

However, research is still underway and the effectiveness and reliability of canine cancer detection requires further research.

Explore more such interesting information by joining us at World Hematology 2019, this July at Rome, Italy

Source: https://www.medicalnewstoday.com/articles/323620.php

Track 19 : Hematology & Oncology: Case Reports

Case reports are detailed reports that has all the signs, symptoms, diagnosis, treatment and follow up of the patients. These case reports serve as an evidence for medicine, scientific and educational purposes. Case reports of hemotology or oncology gives the information of preventive or therapeutic interventions as these generally require stronger evidence. Thus, a case report has all the details of a disease or a disorder of an individual in medical field. Case reports give the demographic profile of the patient suffering from disease, references of any unusual or unique incidences, etc.

Do submit your abstracts in the following link: Abstract-Submission

Do you know?

Do you know that one pint of blood is capable of saving 3 lives and people suffering from sickle cell disease need up to 4 pints or units of blood every single month to survive.

Know more such interesting facts and work on hematology, oncology at: World Hematology 2019

Do you Know?

Are you curious to know, why red blood cells are shaped like breath-mint disks with a dent in the middle?

The answer to this query seems interesting, this is because, the breath-mint design allows the cells to twist through capillaries and the tiniest blood vessels. A sphere or cube is less flexible and might get stuck. Also, the dents in the cells add to the surface area, allowing more oxygen and carbon dioxide to pass in and out of the cell.

To know more interesting facts about hematology/ oncology, PS:https://bit.ly/2KAr8Bq

Join us this July, to unleash the enigmas in hem/ onc, PS: http://medicines.doctor/haematology5

World Hematology 2019

Here we have our media partners who support us in making our event. Do join us at Rome, Italy to unravel the conundra in hematology/ oncology. For more details, PS: http://medicines.doctor/haematology5

Do you know?

For the first time in 27 years, the FDA has proposed amending mammography screening regulations. On March 27, 2019, the FDA proposed policy changes to modernize mammography services. “Among the proposed amendments to improve communication and medical decision making is the addition of breast density information to the mammography lay summary letter provided to patients and to the medical report provided to their referring health care professionals. Mammograms of dense breasts—breasts with a higher proportion of fibroglandular tissue compared to fatty tissue—can be difficult to interpret because the dense tissue can obscure signs of breast cancer and lower the sensitivity of the image. Dense breasts have also been identified as a risk factor for developing breast cancer,” according to an FDA news release.

The proposed amendments also seek to enhance information provided to health care professionals by proposing to codify three additional categories for the assessments of mammograms, including adding an important category titled “known biopsy proven malignancy,” which would help identify for health care professionals those cases where cancer being mammographically evaluated for therapy are already known and identified. The proposed amendments would also modernize mammography quality standards and better position FDA to enforce the MQSA regulations and take action when violations are found.

Source: https://www.mdedge.com/hematology-oncology/quiz/7746/fast-facts-friday/fast-facts-friday-march-29-2019?channel=59610